Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma

Terri S. Armstrong; Jeffrey S. Wefel; Meihua Wang; Mark R. Gilbert; Minhee Won; Andrew Bottomley; Tito R. Mendoza; Corneel Coens; Maria Werner-Wasik; David G. Brachman; Ali K. Choucair; Minesh Mehta

doi:10.1200/JCO.2013.49.6067

Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma

Terri S. Armstrong, Jeffrey S. Wefel, Meihua Wang, Mark R. Gilbert, Minhee Won, Andrew Bottomley, Tito R. Mendoza, Corneel Coens, Maria Werner-Wasik, David G. Brachman, Ali K. Choucair, Minesh Mehta

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Journal of Clinical Oncology
Volume	31
DOIs	https://doi.org/10.1200/JCO.2013.49.6067
State	Published - Nov 10 2013

Disciplines

Physical Therapy
Medicine and Health Sciences
Pathology

Access to Document

10.1200/JCO.2013.49.6067License: Unspecified

Cite this

Armstrong, T. S., Wefel, J. S., Wang, M., Gilbert, M. R., Won, M., Bottomley, A., Mendoza, T. R., Coens, C., Werner-Wasik, M., Brachman, D. G., Choucair, A. K., & Mehta, M. (2013). Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma. Journal of Clinical Oncology, 31. https://doi.org/10.1200/JCO.2013.49.6067

Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma. / Armstrong, Terri S.; Wefel, Jeffrey S.; Wang, Meihua et al.
In: Journal of Clinical Oncology, Vol. 31, 10.11.2013.

Research output: Contribution to journal › Article › peer-review

Armstrong, TS, Wefel, JS, Wang, M, Gilbert, MR, Won, M, Bottomley, A, Mendoza, TR, Coens, C, Werner-Wasik, M, Brachman, DG, Choucair, AK & Mehta, M 2013, 'Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma', Journal of Clinical Oncology, vol. 31. https://doi.org/10.1200/JCO.2013.49.6067

@article{9167f0d055eb4ab6971d58b09136857f,

title = "Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma",

author = "Armstrong, {Terri S.} and Wefel, {Jeffrey S.} and Meihua Wang and Gilbert, {Mark R.} and Minhee Won and Andrew Bottomley and Mendoza, {Tito R.} and Corneel Coens and Maria Werner-Wasik and Brachman, {David G.} and Choucair, {Ali K.} and Minesh Mehta",

note = "In order to access this website, please configure your browser to support cookies.",

year = "2013",

month = nov,

day = "10",

doi = "10.1200/JCO.2013.49.6067",

language = "American English",

volume = "31",

journal = "Journal of Clinical Oncology",

}

TY - JOUR

T1 - Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma

AU - Armstrong, Terri S.

AU - Wefel, Jeffrey S.

AU - Wang, Meihua

AU - Gilbert, Mark R.

AU - Won, Minhee

AU - Bottomley, Andrew

AU - Mendoza, Tito R.

AU - Coens, Corneel

AU - Werner-Wasik, Maria

AU - Brachman, David G.

AU - Choucair, Ali K.

AU - Mehta, Minesh

N1 - In order to access this website, please configure your browser to support cookies.

PY - 2013/11/10

Y1 - 2013/11/10

UR - http://ascopubs.org/doi/10.1200/JCO.2013.49.6067

U2 - 10.1200/JCO.2013.49.6067

DO - 10.1200/JCO.2013.49.6067

M3 - Article

VL - 31

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

ER -

Net Clinical Benefit Analysis of Radiation Therapy Oncology Group 0525: A Phase III Trial Comparing Conventional Adjuvant Temozolomide With Dose-Intensive Temozolomide in Patients With Newly Diagnosed Glioblastoma

Disciplines

Access to Document

Other files and links

Cite this